Trends in Clinical Proteomics

The Clinical proteomics is a field of identification of Biomarkers for diagnosis and therapeutic intervention of any kind of disease by comparing the proteomic profiles, disease, and differing physiological states. The renal disease diagnosis also plays a vital role in proteomics for diagnosis of the disease which relates to kidney. The application of proteomics in other nonclinical settings is very much limited by various factors that affect their reproducibility, resolution and clarity of separation. The Fetal and Maternal analysis is the interpretation technique, in the maternal analysis the blood screening is done in order to know the status of infant health. As per the report, the fetal DNA ranges from about 2-10% of the total DNA in maternal blood. The biochemistry relates with proteomics where it is concerned with the chemical and physio-chemical process and the substance which occur within the living organisms.

Some related Conferences:

5th International Conference on Clinical Microbiology and Microbial Genomics October 24-26, 2016 Rome, Italy; International Conference on Clinical and Molecular Genetics November 28-30, 2016 Chicago, USA; Clinical Nurse Specialist Annual Meeting November 7-9, 2016 Melbourne, Australia; 5th International Conference on Clinical Nutrition November 28-30, 2016 San Antonio, USA; 8th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 San Francisco, USA; 11th Biomarkers Congress Feburary 25-26, 2016, UK; Genomics and Data Integration, Analysis and Visualization March 10-11, 2016 San Francisco, USA; 36th BMSS meeting September15-17, 2015 Birmingham, UK; 21st Reid Bio analytical chromatography Forum September 7-10, 2015 Guildford, UK; Asilomar Conference-Native Mass Spectrometry-based Structural Biology October 16-20, 2015 UK.

Chronic kidney disease (CKD) is a main cause of the chronic renal failure. This increase is not only painful for CKD patients, but also serious problem for social medication. To gain a full understanding of cancer biology and to be able to translate this information to the clinic requires substantial information about the proteome through the course of disease. Improved technology means that vast amounts of information about the cancer proteome are being generated. Proteomics-based techniques allow the identification of biomarkers and protein expression signatures, which could be used to predict responses to drugs and the clinical course of disease, and such information, could be used to individualize therapy. Advancement in electrophoresis and mass spectrometry techniques along with the recent progresses in genomics, culminating in bovine and pig genome sequencing, widened the potential application of proteomics in the field of veterinary medicine. The Biomedical Proteomics develop capability for advanced protein discovery using mass spectrometry. In Fetal and Maternal Analysis, High-throughput paired-end sequencing to directly measure the size distributions of maternal and fetal DNA in cell-free maternal plasma collected from 3 typical diploid and 4 aneuploidy male pregnancies. As a control, restriction fragments of lambda DNA were also sequenced.

  • Cancer Proteomics
  • Renal proteome
  • Fetal and Maternal Analysis
  • Biomedical Proteomics
  • Veterinary Proteomics

Related Conference of Trends in Clinical Proteomics

Trends in Clinical Proteomics Conference Speakers